Concepedia

Pfizer (Japan)

P(

Statistics

Publications

1.1K

Citations

60K

Authors

176

Location

Tokyo, Japan

Also known as ファイザ

Pfizer (Japan) is a company institution in Tokyo, Japan known for medicine, pharmacology, and pharmacotherapy.

HomepageWikipediaROR

Top concepts

Publications

1.1K

Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

Yoshiya Tanaka, Makoto Suzuki, Hiroyuki Nakamura et al. · Arthritis Care & Research · 2011 · 295 citations

Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity

Chung‐Ren Lin, Fumimasa Amaya, Lee Barrett et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 249 citations

The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

Jeffrey L. Stock, Katsuhiro Shinjo, John Burkhardt et al. · Journal of Clinical Investigation · 2001 · 235 citations · Full text

PAMPA—critical factors for better predictions of absorption

Alex Avdeef, Stefanie Bendels, Lei Di et al. · Journal of Pharmaceutical Sciences · 2007 · 235 citations

, , +4

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey et al. · Arthritis & Rheumatology · 2017 · 232 citations · Full text

Rows per page

1–5 of 1.1K

Authors

176

  1. YK
    Yasuhiro Kojima

    Pfizer (Japan), Japan

    153 publications · 1.3K citations

    20

    h-index

  2. YU
    Yoshiko Umeyama

    Pfizer (Japan), Japan

    52 publications · 1K citations

    18

    h-index

  3. SW
    Shuzo Watanabe

    Pfizer (Japan), Japan

    50 publications · 1.3K citations

    17

    h-index

  4. SS
    Shinichi Sakemi

    Pfizer (Japan), Japan

    24 publications · 1.4K citations

    17

    h-index

  5. YK
    Yoon-Jeong Kim

    Pfizer (Japan), Japan

    110 publications · 796 citations

    16

    h-index

Rows per page

1–5 of 176